Feature

Supreme Court roundup: Latest health care decisions


 

Court to hear women’s health cases

Two closely watched reproductive health cases will go before the court this spring.

On March 4, justices will hear oral arguments in June Medical Services v. Russo, regarding the constitutionality of a Louisiana law that requires physicians performing abortions to have admitting privileges at a nearby hospital. Doctors who perform abortions without admitting privileges at a hospital within 30 miles face fines and imprisonment, according to the state law, originally passed in 2014. Clinics that employ such doctors can also have their licenses revoked.

June Medical Services LLC, a women’s health clinic, sued over the law. A district court ruled in favor of the plaintiff, but the 5th U.S. Circuit Court of Appeals reversed and upheld Louisiana’s law. The clinic appealed to the U.S. Supreme Court. Louisiana officials argue the challenge should be dismissed, and the law allowed to proceed, because the plaintiffs lack standing.

The Supreme Court in 2016 heard a similar case – Whole Woman’s Health v. Hellerstedt – concerning a comparable law in Texas. In that case, justices struck down the measure as unconstitutional.

And on April 29, justices will hear arguments in Little Sisters of the Poor v. Pennsylvania, a consolidated case about whether the Trump administration acted properly when it expanded exemptions under the Affordable Care Act’s contraceptive mandate. Entities that object to providing contraception on the basis of religious beliefs can opt out of complying with the mandate, according to the 2018 regulations. Additionally, nonprofit organizations and small businesses that have nonreligious moral convictions against the mandate can skip compliance. A number of states and entities sued over the new rules.

A federal appeals court temporarily barred the regulations from moving forward, ruling the plaintiffs were likely to succeed in proving the Trump administration did not follow appropriate procedures when it promulgated the new rules and that the regulations were not authorized under the ACA.

Justices will decide whether the parties have standing in the case, whether the Trump administration followed correct rule-making procedures, and if the regulations can stand.

Pages

Recommended Reading

CMS proposes second specialty tier for Medicare drugs
MDedge Dermatology
What you absolutely need to know about tail coverage
MDedge Dermatology
Be alert for embezzlement
MDedge Dermatology
Trump seeks to cut NIH, CDC budgets, some Medicare spending
MDedge Dermatology
50 years of growth: More dermatologists, more demand
MDedge Dermatology
Private equity firms acquiring more physician group practices
MDedge Dermatology
My inspiration
MDedge Dermatology
‘Momentous’ USMLE change: New pass/fail format stuns medicine
MDedge Dermatology
FDA, FTC uniting to promote biosimilars
MDedge Dermatology
Pondering jumping into teledermatology?
MDedge Dermatology